Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens

被引:51
作者
Lemieux, GA
Bertozzi, CR [1 ]
机构
[1] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA
来源
CHEMISTRY & BIOLOGY | 2001年 / 8卷 / 03期
关键词
sialic acid; antibody; immune response; oligosaccharide; tumor;
D O I
10.1016/S1074-5521(01)00008-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Sialic acid is a component of many tumor-associated oligosaccharide antigens. The repertoire of sialic acids presented by cells can be expanded to include unnatural variants by intercepting the sialic acid biosynthetic pathway with unnatural precursors. We explored whether unnatural cell surface sialosides produced by metabolism can act as neo-antigens and modulate the immunogenicity of cells. Results: Immunization of rabbits with synthetic conjugates of an unnatural sialic acid bound to keyhole limpet hemocyanin produced significant titers of antibodies that were specific for the structurally altered sialic acid. The antibodies recognized cells that were fed the unnatural biosynthetic precursor, and were capable of directing complement-mediated lysis. Conclusions: Structural alteration of sialic acids replaces a tolerized self-antigen with an antigenic determinant. Incorporation of unnatural sialosides into cell surface glycoconjugates through biosynthetic means can alter the immunoreactivity of cells, providing new possibilities for tumor immunotherapy. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 46 条
[1]   CELLULAR MUCINS - TARGETS FOR IMMUNOTHERAPY [J].
APOSTOLOPOULOS, V ;
MCKENZIE, IFC .
CRITICAL REVIEWS IN IMMUNOLOGY, 1994, 14 (3-4) :293-309
[2]   Pathways of O-glycan biosynthesis in cancer cells [J].
Brockhausen, I .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :67-95
[3]   Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells [J].
Cappello, S ;
Liu, NX ;
Musselli, C ;
Brezicka, FT ;
Livingston, PO ;
Ragupathi, G .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (09) :483-492
[4]  
COLLARD JG, 1986, CANCER RES, V46, P3521
[5]   Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells [J].
Collins, BE ;
Fralich, TJ ;
Itonori, S ;
Ichikawa, Y ;
Schnaar, RL .
GLYCOBIOLOGY, 2000, 10 (01) :11-20
[6]  
Danishefsky SJ, 2000, ANGEW CHEM INT EDIT, V39, P836, DOI 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO
[7]  
2-I
[8]   Glycoprotein glycosylation and cancer progression [J].
Dennis, JW ;
Granovsky, M ;
Warren, CE .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :21-34
[9]   SPECIFICITIES OF HUMAN HETEROPHILIC HANGANUTZIU AND DEICHER (H-D) ANTIBODIES AND AVIAN ANTISERA AGAINST H-D ANTIGEN-ACTIVE GLYCOSPHINGOLIPIDS [J].
FUJII, Y ;
HIGASHI, H ;
IKUTA, K ;
KATO, S ;
NAIKI, M .
MOLECULAR IMMUNOLOGY, 1982, 19 (01) :87-94
[10]  
Fukuda M, 1996, CANCER RES, V56, P2237